Rosemary Schroyer

Statistics

Publications

Citations

194

H-Index

Active since

2010

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

Addenbrooke's Hospital

Rosemary Schroyer is an author at GlaxoSmithKline (United States) specializing in pharmacology, clinical pharmacology, and cardiovascular drug safety.

Publications per year

2010–2021

Publications

Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects

Navin Goyal, Peter J. Skrdla, Rosemary Schroyer et al. · American Journal of Cardiovascular Drugs · 2019 · 147 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

A pilot study evaluating GSK1070806 inhibition of interleukin-18 in renal transplant delayed graft function

Elizabeth Wlodek, Robert B. Kirkpatrick, Susan Andrews et al. · PLoS ONE · 2021 · 25 citations · Full text

Medicine, Immunology, Nephrology +17

Long-term up to 24-month efficacy and safety of concomitant prescription omega-3-acid ethyl esters and simvastatin in hypertriglyceridemic patients

Harold Bays, Kevin C. Maki, James M. McKenney et al. · Current Medical Research and Opinion · 2010 · 22 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

1–3 of 3